MITRAGYNINE ANALOGS AND USES THEREOF
Described herein are compounds of Formulae (I')-(II'), compounds of Formulae (I)-(II), and pharmaceutically acceptable salts thereof. Compounds of the present invention are useful for modulating opioid receptor activity. The provided compounds may have both agonistic and antagonistic effect on one or more opioid receptors. Methods of using the compounds for treating or managing pain are also described..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 27. Sept. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
PASTERNAK GAVRIL [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-09-27, Last update posted on www.tib.eu: 2023-10-10, Last updated: 2023-10-13 |
|---|
| Patentnummer: |
EP4212532 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA017707528 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA017707528 | ||
| 003 | DE-627 | ||
| 005 | 20231013140338.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230728s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA017707528 | ||
| 035 | |a (EPA)EP4212532 | ||
| 035 | |a (EPA)57198749 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a PASTERNAK GAVRIL |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a MITRAGYNINE ANALOGS AND USES THEREOF |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-09-27, Last update posted on www.tib.eu: 2023-10-10, Last updated: 2023-10-13 | ||
| 520 | |a Described herein are compounds of Formulae (I')-(II'), compounds of Formulae (I)-(II), and pharmaceutically acceptable salts thereof. Compounds of the present invention are useful for modulating opioid receptor activity. The provided compounds may have both agonistic and antagonistic effect on one or more opioid receptors. Methods of using the compounds for treating or managing pain are also described. | ||
| 650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a MAJUMDAR SUSRUTA |4 aut | |
| 700 | 0 | |a KARIMOV RASHAD |4 aut | |
| 700 | 0 | |a VARADI ANDRAS |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 27. Sept. |
| 773 | 1 | 8 | |g year:2023 |g day:27 |g month:09 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/57198749/publication/EP4212532A1?q=EP4212532 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2023 |b 27 |c 09 |
| 951 | |a AR | ||
| 952 | |j 2023 |b 27 |c 09 | ||